Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Research Type:

Sort 1 results by:

Filter Applied. Clear All

Latest Posts

April 14, 2026 Drug-induced Abortion After the First Trimester Drug-induced Abortion After the First Trimester April 10, 2026 Abortion Law in America Today: Confronting Infringements on Pro-life Laws Abortion Law in America Today: Confronting Infringements on Pro-life Laws April 9, 2026 New Study: Most Women Seeking Abortion Have Higher Risk of Negative Psychological Reactions New Study: Most Women Seeking Abortion Have Higher Risk of Negative Psychological Reactions
Reset All Filters
Life & the Law

Written Testimony of Dr. Ingrid Skop on Interstate Travel for Abortion

On June 12, CLI VP of Medical Affairs Dr. Ingrid Skop testified on the issue of interstate travel for abortion before the Subcommittee on Federal Courts, Oversight, Agency Action, and Federal Rights of the U.S. Senate Committee on the Judiciary. Dr. Skop responded to a number of misconceptions about the alleged need for women to travel out of state for abortion.

Welcomed Pregnancies: Characteristics and Patterns of Adjusting to Unwanted, Unplanned, Untimely or Otherwise Difficult Pregnancies
Maternal & Public Health

Welcomed Pregnancies: Characteristics and Patterns of Adjusting to Unwanted, Unplanned, Untimely or Otherwise Difficult Pregnancies

In this study, women dealing with pregnancies that were problematic and who did not choose abortion experienced rapid improvements in feelings of wantedness, acceptance, timeliness, desirability, and welcoming toward the pregnancy. The improvement rate was quickest among women who investigated and considered abortion. Women who reported contact with pregnancy help centers nearly always said it improved their lives.

Maternal & Public Health

Abortion Reporting: Arkansas (2023)

Arkansas reported zero abortions in 2023 as of June 3, 2024. 

Maternal & Public Health

Abortion Reporting: West Virginia (2023)

West Virginia’s 2023 abortion statistics by quarter were published throughout 2023 and into March 2024, showing that abortions in the Mountain State have decreased exponentially since 2022.

Maternal & Public Health

Abortion Reporting: Indiana (2023)

Indiana changed to quarterly reporting for 2023 and, as a result, this data represents the summation of the data in the quarterly reports. These reports showed that abortions in Indiana decreased significantly from 2022, likely due to the state’s life at conception law going back into effect in late August 2023.

Abortion

Fact Sheet: Reasons for Abortion

After the Supreme Court ruling in Dobbs v. Jackson Women’s Health Organization, states across the country have enacted laws that limit abortion. Frequently, these laws make exceptions for abortions for certain reasons, such as rape and incest, risk to the mother’s life or health, or a fetal abnormality. This fact sheet documents how common, or uncommon, these various reasons for abortion are.

United Kingdom Data Deficiencies Influencing U.S. FDA Decisions
Life & the Law

United Kingdom Data Deficiencies Influencing U.S. FDA Decisions

CLI's VP of Medical Affairs Ingrid Skop, together with Calum Miller, MD, and Kevin Duffy, MPH, recently published an article in Issues in Law & Medicine arguing that decisions by the FDA to pull back regulations on the abortion drug mifepristone in part relied on "flawed studies with significantly undercounted complications" from the U.K.

Life & the Law

Misleading Statements About “Life of the Mother” Exceptions in Pro-life Laws Require Correction

Recently CLI scholars Ingrid Skop, M.D. and Mary Harned, J.D. published a rebuttal in Issues in Law & Medicine to a series of misleading statements made in an article that appeared in the journal Obstetrics & Gynecology.

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image